Nexien BioPharma Inc (NXEN)

[High_Profits]

New CEO Interview [VIDEO] with Jeff Friedland - $KDRHD $NTVA Intiva Biopharma

Video Link ...

In this episode we continue our series on the emerging legal cannabis industry and will be speaking with industry expert, investor and speaker, Mr. Jeffrey Friedland who is also author of the book, "Marijuana: The World’s Most Misunderstood Plant".

Mr. Friedland is also currently CEO of Intiva BioPharma, Inc. ($KDRHD) ($NTVA)

INTIVA BioPharma Inc. ("INTIVA”) is pursuing the formulation of cannabinoid-based drugs for various medical conditions and disorders, all under U.S. Food and Drug Administration (FDA) development pathways.

ArcView Market Research estimates that America's pharmaceutical cannabis sector could reach over $23 billion by 2020. Research published by New Frontier Data indicates that the United States constitutes 35% of the global pharmaceutical market, the largest market in the world, and a major driver of the U.S. economy. New Frontier has indicated that cannabinoid-derived drugs and related products could replace $4.4 to $4.9 billion annually spent on existing treatments.